These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36822333)

  • 41. Anti-allergic activity of formoterol, a new beta-adrenoceptor stimulant, and salbutamol in human leukocytes and human lung tissue.
    Mita H; Shida T
    Allergy; 1983 Nov; 38(8):547-52. PubMed ID: 6197899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. β
    Kim SH; Yi SJ; Lee H; Kim JH; Oh MJ; Song EJ; Kim K; Jhun BH
    Anim Cells Syst (Seoul); 2019 Feb; 23(1):18-25. PubMed ID: 30834155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta
    Hostrup M; Narkowicz CK; Habib S; Nichols DS; Jacobson GA
    Drug Test Anal; 2019 Jul; 11(7):1048-1056. PubMed ID: 30836453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders.
    Clausen L; Cossins J; Beeson D
    J Neuromuscul Dis; 2018; 5(2):231-240. PubMed ID: 29865088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of uncoupling proteins by beta-adrenergic stimulation in L6 myotubes.
    Nagase I; Yoshida T; Saito M
    FEBS Lett; 2001 Apr; 494(3):175-80. PubMed ID: 11311236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roflumilast N-Oxide in Combination with Formoterol Enhances the Antiinflammatory Effect of Dexamethasone in Airway Smooth Muscle Cells.
    Patel BS; Rahman MM; Baehring G; Xenaki D; Tang FS; Oliver BG; Ammit AJ
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):532-538. PubMed ID: 27997807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation.
    Noguchi T; Nakagome K; Kobayashi T; Ueda Y; Soma T; Nakamoto H; Nagata M
    Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice.
    Koopman R; Gehrig SM; Léger B; Trieu J; Walrand S; Murphy KT; Lynch GS
    J Physiol; 2010 Dec; 588(Pt 23):4811-23. PubMed ID: 20937713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial.
    Zügel M; Bizjak DA; Nussbaumer D; Winkert K; Takabayashi K; Kirsten J; Washington M; Treff G; Dreyhaupt J; Steeb L; Diel P; Parr MK; Steinacker JM; Persch H
    Trials; 2021 Dec; 22(1):903. PubMed ID: 34895300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.
    Oehme S; Mittag A; Schrödl W; Tarnok A; Nieber K; Abraham G
    Pulm Pharmacol Ther; 2015 Feb; 30():110-20. PubMed ID: 24915152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors.
    Lewis RJ; Chachi L; Newby C; Amrani Y; Bradding P
    J Immunol; 2016 Jan; 196(1):55-63. PubMed ID: 26608913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concomitant inhaled corticosteroid resensitises cardiac beta2-adrenoceptors in the presence of long-acting beta2-agonist therapy.
    Aziz I; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1998 Jul; 54(5):377-81. PubMed ID: 9754979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of short- and long-acting beta 2-adrenoceptor agonists on pulmonary beta 2-adrenoceptor expression in human lung.
    Nishikawa M; Mak JC; Barnes PJ
    Eur J Pharmacol; 1996 Dec; 318(1):123-9. PubMed ID: 9007523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formoterol in clinical practice--safety issues.
    Rabe KF
    Respir Med; 2001 Aug; 95 Suppl B():S21-5. PubMed ID: 11534893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
    Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
    Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of beta 2-adrenoceptor agonists against platelet-activating factor-induced airway microvascular leakage and bronchoconstriction in the guinea pig.
    Sakamoto T; Barnes PJ; Chung KF
    Agents Actions; 1993 Sep; 40(1-2):50-6. PubMed ID: 7908496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells.
    Mamani-Matsuda M; Moynet D; Molimard M; Ferry-Dumazet H; Marit G; Reiffers J; Mossalayi MD
    Br J Haematol; 2004 Jan; 124(2):141-50. PubMed ID: 14687023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta
    Hostrup M; Knudsen JG; Kristensen CM; Jessen S; Pilegaard H; Bangsbo J
    Scand J Med Sci Sports; 2022 Jul; 32(7):1099-1108. PubMed ID: 35460295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dynamic ribosomal biogenesis response is not required for IGF-1-mediated hypertrophy of human primary myotubes.
    Crossland H; Timmons JA; Atherton PJ
    FASEB J; 2017 Dec; 31(12):5196-5207. PubMed ID: 28774889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.